Leading change in cancer services requires more than generating evidence. It requires collaboration, implementation, and a focus on improving patient care. Join A/Prof Marliese Alexander as she shares lessons from three interconnected research programs spanning real-world evidence in thoracic cancers (AURORA), precision oncology and pharmacogenomics, and cancer-associated thrombosis.
Through these examples, she will explore how clinician-led research can inform practice, influence policy, and translate innovation into routine cancer care.
A/Prof Alexander is a pharmacist-researcher dedicated to enhancing cancer care by optimising medication use, improving treatment outcomes, and reducing toxicities. With expertise in oncology pharmacy, thoracic cancers, clinical trials, and population studies, her research focuses on biomarker-driven therapies, pharmacogenomics, longitudinal registries, and biobanking.
A/Prof Alexander leads programs integrating clinical, health services, and translational studies to advance personalised medicine for supportive care and leverage real-world data to inform cancer research. She is the lead investigator for the multisite PRECISION trial on pharmacogenomic optimisation of cancer medicines and co-leads the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA).
